Navigation Links
Health Canada bewilligt gesundheitsbezogene Angaben für fünf probiotische Rezepturen von Lallemand
Date:2/20/2013

:
"Hilft, das Risiko von antibiotikaassoziiertemDurchfall zu senken" (Angabe NPN 80038395).

Der probiotische Nutzen dieser Produkte mit Angaben wie "Probiotisch zum Wohle der Gesundheit und/oder mit gesundheitsförderndem Nutzen" oder "Probiotisch für eine natürlich gesunde Darmflora" wurde bereits von der kanadischen Gesundheitsbehörde anerkannt.

Die Realisierung der Zulassung dieser für spezifische Bedürfnisse geltenden Angaben ermöglicht dem Endverbraucher, den angestrebten gesundheitlichen Nutzen der probiotischen Rezepturen von Lallemand zu verstehen. Dadurch wird die Position von Lallemands Kunden in einem bereits expandierenden und wettbewerbsorientierten Markt weiter gestärkt. 

Lallemand Health Solutions

Lallemand Health Solutions ist danach bestrebt, seinen Kunden aus der Nahrungsergänzungs- oder pharmazeutischen Branche die hochwertigsten probiotischen Lösungen zu liefern, die in den aktuellen GMP und ISO 9001 Umgebungen hergestellt werden. LHS ist dank seines komplett integrierten Angebotes ein bedeutender Akteur in der globalen Arena, der seinen Kunden und Partnern Lösungen von der Fermentation und Gefriertrocknung bis hin zum fertigen Produkt liefern kann. Lallemand Health Solutions versorgt Kunden in über 30 Ländern auf fünf Kontinenten.

Um ausführlichere Informationen zu erhalten, besuchen Sie bitte http://www.lallemand-health-solutions.com oder schicken Sie eine E-Mail an healthsolutions@lallemand.com.

Ansprechpartner für die Medien:

Sylvie Roquefeuil
Tel.: +33(0)6-84-72-76-10
E-Mail: sroquefeuil@lallemand.com


'/>"/>
SOURCE Lallemand Health Solutions
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
8. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
9. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... OH (PRWEB) January 22, 2015 Crystal Diagnostics ... today that it has received AOAC-PTM Certifications for the six ... O121, and O145; collectively referred to as STEC or the ... 1 colony forming unit (cfu) per 325 g of raw ...
(Date:1/22/2015)... January 22, 2015 Selexis SA, a ... Research Cell Banks (RCBs) used for drug discovery to ... Banks will include Next-Generation Sequencing (NGS) data ... de-risks biologic manufacturing by ensuring the integrity of the ...
(Date:1/22/2015)... GenoSpace , a precision medicine software company that has developed ... of genomic, imaging and other biomedical data in research and ... , CEO of Aspera, an IBM Company, to its board ... "We are pleased to welcome Michelle ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... N.J. , Jan. 27 Covance Inc. (NYSE: ... 31, 2009 of $0.64 per diluted share.  For the ... inclusive of $0.10 per share in gains related to sales ... the third quarter.  Excluding the gains on sales and the tax item, ...
... ... leaders at Biomanufacturing Summit in La Jolla, California January 26th and 27th, 2010. ... Fort Collins, CO ... InVitria’s products enable its customers to optimize their biomanufacturing process from the cell bank ...
... , , , , ... January 27 Jubilant Biosys,Ltd., a subsidiary of Jubilant ... Pa. , U.S.A., announced today that they have,expanded their drug ... stage milestone. , The year-old partnership ...
Cached Biology Technology:Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 2Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 3Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 4Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 5Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 6Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 7Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 8Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 9Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 10Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 11Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 12Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 13Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 14Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 15Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 16Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 17InVitria Sponsors 2010 Biomanufacturing Summit 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 3
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... commerce market, reports on the recent success of the Wocket™ smart wallet ... Wocket smart wallet was named as one of the "11 Hot ... "5 Best Products Launched At CES So Far" by Newseveryday.com and "The ...
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
(Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... mother,s diet may be able to interact with the genes ... of birth defect according to research funded by the Wellcome ... in the journal Human Molecular Genetics , suggests that ... pregnancy could be inadvertently putting the health of their offspring ...
... mechanism by which a herpes virus invades cells has remained ... viruses. New research funded by the National Institutes of Health ... Structural & Molecular Biology reveals the unusual structure of ... cells. This detailed map of a key piece of the ...
... 6, 2010 Investigators at the Translational Genomics Research Institute ... patients who no longer respond to conventional chemotherapy. A ... of the journal Gynecologic Oncology describes how the ... to incorporate into therapies for women with ovarian cancer. ...
Cached Biology News:Maternal diet and genes interact to affect heart development 2Maternal diet and genes interact to affect heart development 3Map of herpes virus protein suggests a new drug therapy 2TGen finds protein inhibitor revives chemotherapy for ovarian patients 2TGen finds protein inhibitor revives chemotherapy for ovarian patients 3